The expert panel of India's drug regulator, DCGI, has permitted Bharat Biotech to give the third dose of Covaxin to a few volunteers in its clinical trials of the COVID-19 vaccine.
Bharat Biotech had applied for emergency use authorisation for its vaccine candidate, Covaxin, in Nepal on January 13. Covaxin demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials India.
The high court also asked the Centre to explain in affidavit the rationale behind keeping strict control over class of persons who can be vaccinated against COVID-19 currently as under the present system those above the age of 60 years or between 45 to 60 years with comorbidities can receive vaccination.
India's indigenously developed vaccine against coronavirus COVAXIN has demonstrated an interim vaccine efficacy of 81 per cent in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR, informed vaccine maker Bharat Biotech.
India's indigenously developed vaccine against coronavirus COVAXIN has demonstrated an interim vaccine efficacy of 81 per cent in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR, informed vaccine maker Bharat Biotech.
A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers whose coronavirus shots are being used in the country's immunisation campaign, cyber intelligence firm Cyfirma told Reuters.
Chinese and Russian-linked hacking campaigns in recent weeks targeted Indian vaccine makers Serum Institute of India (SII) and Bharat Biotech, cyber intelligence and threat discovery platform Cyfirma said on Monday.
Prime Minister Narendra Modi took his first dose of the coronavirus vaccine on Monday. Taking to Twitter, PM Modi today said, "Took my first dose of the COVID-19 vaccine at AIIMS." Modi also lauded the doctors and scientists of the country and said they have worked in quick time to strengthen the global fight against COVID-19. "Remarkable how our doctors and scientists have worked in quick time to strengthen the global fight against COVID-19," Prime Minister Modi wrote on Twitter.
Union Minister Ravi Shankar Prasad on March 01 said that Prime Minister Narendra Modi has replied to all the people questioning that when will he get vaccinated. He further requested Opposition to unite in efforts against Corona rather than using it as a political tool.
Prime Minister Narendra Modi took his first dose of the COVAXIN (Bharat Biotech) at Delhi's AIIMS on March 01 as the second phase of vaccination drive began in India today.
Prime Minister Narendra Modi took his first dose of COVID-19 vaccine at AIIMS Delhi on March 01.
Prime Minister Narendra Modi took his first dose of the coronavirus vaccine on Monday. Taking to Twitter, PM Modi today said, "Took my first dose of the COVID-19 vaccine at AIIMS."
Prime Minister Narendra Modi took his first dose of the coronavirus vaccine on Monday. Taking to Twitter, PM Modi today said, "Took my first dose of the COVID-19 vaccine at AIIMS."
So far Brazil has vaccinated less than 4 per cent of its population of 210 million people, with some cities stopping immunization campaigns last week due to shortages.
Makers of Covaxin, Bharat Biotech has said that they can modify the vaccine against coronavirus South African variant within 15 days. Bharat Biotech's developed India's own vaccine Covaxin against Covid-19 and was rolled out on January 16.
The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot.
India will start supplying hundreds of thousands of doses of ‘Covishield’ vaccine on a grant basis to key neighbours beginning with 2,50,000 vaccine doses for Bhutan and Maldives. Other countries like Bangladesh and Nepal are likely to receive their supplies on Thursday.
Ninety-two countries have approached India for Covid-19 vaccines, bolstering New Delhi's credentials as the vaccine hub of the world.
Covaxin is one of the two drugs approved for emergency use in India. It is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and National Institute of Virology.
Out of the 45 lakh doses, the city-based vaccine maker will be supplying over eight lakh to some of the friendly countries such as Mauritius, Philippines and Myanmar, free of cost as good will gesture sources added.
Top News
Latest News
